Age Ageing
Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Republic of Korea.
Published: June 2022
Background: active screening can improve health outcomes for people with prediabetes. However, its efficacy in older adults remains uncertain.
Objective: the study aimed to analyse the progression from prediabetes to diabetes in older adults, including associated complications and mortality rates, to determine the benefits of active screening.
Design: retrospective cohort study.
Setting: Korean National Health Insurance Service claims database.
Subjects: a total of 36,946 adults aged ≥65 years who underwent national health examinations from 2006 to 2008.
Methods: follow-up was until 31 December 2015. Cox's proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for death and diabetic complications.
Results: over a median follow-up of 8.2 years, 19.3% of older adults with prediabetes progressed to diabetes. Compared with normoglycaemic adults, the multivariable-adjusted HRs (95% CI) for major adverse cardiovascular events were 1.01 (0.95-1.07), 1.08 (0.95-1.23), 1.14 (1.05-1.23) and 1.50 (1.35-1.68) in adults with prediabetes, newly diagnosed diabetes, diabetes not on insulin and diabetes on insulin, respectively. The corresponding HRs (95% CI) for diabetic retinopathy risk were 1.28 (1.15-1.43), 3.16 (2.71-3.69), 6.58 (6.02-7.19) and 9.17 (8.21-10.24). Diabetic nephropathy risk also significantly increased.
Conclusions: progression from prediabetes to diabetes is an important concern among older adults. Prediabetes is associated with the risk of microvascular complications, but not cardiovascular complications and mortality. Therefore, active regular screening for prediabetes is necessary to prevent microvascular complications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/ageing/afac116 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.